{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:18:31Z","timestamp":1761581911953,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Early diagnosis and treatment are improving significantly the quality of life of patients with cystic fibrosis (CF). This recessive disease is caused by a great variability of mutations in the CF transmembrane conductance (<jats:italic>CFTR<\/jats:italic>) gene, whose spectrum and frequency can be different across populations. <\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We performed a retrospective cross-sectional study of CF patients from the island of S\u00e3o Miguel (Azores, Portugal) through a clinical, genealogical, genetic and epidemiological investigation. The clinical course of patients was analyzed as a whole and according to their genotype.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We identified 14 CF patients within a 23-year period, corresponding to a cumulative incidence of 1:3012 births, being three of them born from consanguineous unions. Genetic analysis revealed three <jats:italic>CFTR<\/jats:italic> genotypes: p.[Ser4Ter];[Gln1100Pro] was present in one patient with a less severe phenotype (1\/14); c.[120del23];p.[Phe508del], a very rare one (2\/14); and p.[Phe508del];[Phe508del] in the remaining patients (11\/14). Clinically, respiratory infections (8\/14) and growth failure (6\/14) were the most common initial manifestations. All patients presented pancreatic dysfunction, with 21.4 and 100% of them showing endocrine and exocrine insufficiency, respectively. As expected, patients with severe phenotype were homozygous for p.Phe508del and had the lowest value of body mass index.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The present study demonstrated that S\u00e3o Miguel Island has an increased incidence of CF when compared to recent Portuguese data (1:7500 live births). It also allowed a comprehensive overview of CF in S\u00e3o Miguel, improving medical practice along with genetic counselling and creating opportunities for genotype-targeted therapies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12887-019-1903-y","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T13:02:51Z","timestamp":1578056571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A comprehensive overview of the cystic fibrosis on the island of S\u00e3o Miguel (Azores, Portugal)"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1032-0695","authenticated-orcid":false,"given":"Joana","family":"Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Gaspar-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concei\u00e7\u00e3o","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia C.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara S.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Carreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Mota-Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"1903_CR1","first-page":"194","volume":"35","author":"SM Paranjape","year":"2014","unstructured":"Paranjape SM, Mogayzel PJ Jr. Cystic fibrosis. Pediatr Ver. 2014;35:194\u2013205.","journal-title":"Pediatr Ver"},{"key":"1903_CR2","volume-title":"Diagn\u00f3stico da fibrose qu\u00edstica em idade pedi\u00e1trica e no adulto","author":"Dire\u00e7\u00e3o Geral de Sa\u00fade de Portugal","year":"2015","unstructured":"Dire\u00e7\u00e3o Geral de Sa\u00fade de Portugal. Diagn\u00f3stico da fibrose qu\u00edstica em idade pedi\u00e1trica e no adulto. Lisboa: Norma de Orienta\u00e7\u00e3o Cl\u00ednica n.\u00b0 031\/2012, DGS; 2015. Portuguese. https:\/\/www.dgs.pt\/directrizes-da-dgs\/...\/norma-n-0322012-de-28122012-png.aspx"},{"key":"1903_CR3","unstructured":"Cystic Fibrosis Genetic Analysis Consortium. Cystic Fibrosis Mutation Database. http:\/\/www.genet.sickkids.on.ca\/StatisticsPage.html. Accessed 6 Dec 2019."},{"key":"1903_CR4","unstructured":"Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry Annual data report 2017. https:\/\/www.cff.org\/Research\/Researcher-Resources\/Patient-Registry\/2017-Patient-Registry-Annual-Data-Report.pdf. Accessed 15 July 2019."},{"key":"1903_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jcf.2013.12.003","volume":"13","author":"K De Boeck","year":"2014","unstructured":"De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros. 2014;13:403\u20139.","journal-title":"J Cyst Fibros"},{"key":"1903_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijns4030022","volume":"4","author":"A Mar\u00e7\u00e3o","year":"2018","unstructured":"Mar\u00e7\u00e3o A, Barreto C, Pereira L, Guedes Vaz L, Cavaco J, Casimiro A, F\u00e9lix M, Reis Silva T, Barbosa T, Freitas C, Nunes S, Fel\u00edcio V, Lopes L, Amaral M, Vilarinho L. Cystic fibrosis newborn screening in Portugal: PAP value in populations with stringent rules for genetic studies. Int J Neonatal Screen. 2018;4:22.","journal-title":"Int J Neonatal Screen"},{"key":"1903_CR7","unstructured":"World Health Organization. Genes and human disease. http:\/\/www.who.int\/genomics\/public\/geneticdiseases\/en\/index2.html. Accessed 15 July 2019."},{"key":"1903_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","volume":"4","author":"K De Boeck","year":"2016","unstructured":"De Boeck K, Amaral MD. Progress in therapies for cystic fibrosis. Lancet Respir Med. 2016;4:662\u201374.","journal-title":"Lancet Respir Med"},{"key":"1903_CR9","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2213-2600(16)30188-6","volume":"4","author":"FAL Marson","year":"2016","unstructured":"Marson FAL, Bertuzzo CS, Ribeiro JD. Classification of CFTR mutation classes. Lancet Respir Med. 2016;4:e37\u20138.","journal-title":"Lancet Respir Med"},{"key":"1903_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3389\/fphar.2017.00390","volume":"8","author":"FAL Marson","year":"2017","unstructured":"Marson FAL, Bertuzzo CS, Ribeiro JD. Personalized or precision medicine? The example of cystic fibrosis. Front Pharmacol. 2017;8:390.","journal-title":"Front Pharmacol"},{"key":"1903_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/MCP.0000000000000479","volume":"24","author":"FAL Marson","year":"2018","unstructured":"Marson FAL. Disease-modifying genetic factors in cystic fibrosis. Curr Opin Pulm Med. 2018;24:296\u2013308.","journal-title":"Curr Opin Pulm Med"},{"key":"1903_CR12","volume":"2016","author":"A Plummer","year":"2016","unstructured":"Plummer A, Wildman M, Gleeson T. Duration of intravenous antibiotic therapy in people with cystic fibrosis. Cochrane Database Syst Rev. 2016;2016:CD006682.","journal-title":"Cochrane Database Syst Rev"},{"key":"1903_CR13","first-page":"129","volume-title":"Human genetic disease","author":"CC Branco","year":"2011","unstructured":"Branco CC, Mota-Vieira L. The genetic makeup of Azoreans versus mainland Portugal population. In: Plaseska-Karanfilska D, editor. Human genetic disease. Macedonia: IntechOpen; 2011. p. 129\u201360."},{"key":"1903_CR14","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","volume":"181S","author":"PM Farrell","year":"2017","unstructured":"Farrell PM, White TB, Hempstead SE, Accurso F, Derichs N, Howenstine M, et al. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181S:S4\u2013S15.e1.","journal-title":"J Pediatr"},{"issue":"Suppl 2","key":"1903_CR15","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","volume":"10","author":"C Bombieri","year":"2011","unstructured":"Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M, Bareil C, Bilton D, Castellani C, Cuppens H, Cutting GR, Drev\u00ednek P, Farrell P, Elborn JS, Jarvi K, Kerem B, Kerem E, Knowles M, Macek M Jr, Munck A, Radojkovic D, Seia M, Sheppard DN, Southern KW, Stuhrmann M, Tullis E, Zielenski J, Pignatti PF, Ferec C. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10(Suppl 2):S86\u2013S102.","journal-title":"J Cyst Fibros"},{"key":"1903_CR16","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Fontana; 2019. Report. https:\/\/goldcopd.org\/. Accessed 15 July 2019"},{"key":"1903_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000257426","volume":"24","author":"AS Ramalho","year":"2009","unstructured":"Ramalho AS, Lewandowska MA, Farinha CM, Mendes F, Gon\u00e7alves J, Barreto C, et al. Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients. Cell Physiol Biochem. 2009;24:335\u201346.","journal-title":"Cell Physiol Biochem"},{"key":"1903_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","volume":"19","author":"R Leclercq","year":"2013","unstructured":"Leclercq R, Cant\u00f3n R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19:141\u201360.","journal-title":"Clin Microbiol Infect"},{"key":"1903_CR19","volume-title":"A history of the Azores islands","author":"JH Guill","year":"1993","unstructured":"Guill JH. A history of the Azores islands. Tulare: Division of Golden Shield International Publications Cooperation; 1993."},{"key":"1903_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1469-1809.2003.00031.x","volume":"67","author":"C Santos","year":"2005","unstructured":"Santos C, Lima M, Montiel R, Angles N, Pires L, Abade A, Aluja MP. (2003) genetic structure and origin of peopling in the Azores islands (Portugal): the view from mtDNA. Ann Hum Genet. 2005;67:433\u201356.","journal-title":"Ann Hum Genet"},{"key":"1903_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1469-1809.2004.00147.x","volume":"69","author":"PR Pacheco","year":"2005","unstructured":"Pacheco PR, Branco CC, Cabral R, Costa S, Ara\u00fajo AL, Peixoto BR, Mendon\u00e7a P, Mota-Vieira L. The Y chromosomal heritage of the Azores islands population. Ann Hum Genet. 2005;69:145\u201356.","journal-title":"Ann Hum Genet"},{"key":"1903_CR22","first-page":"769","volume-title":"Kendig's disorders of the respiratory tract in children","author":"C Wallis","year":"2018","unstructured":"Wallis C. Diagnosis and presentation of cystic fibrosis. In: Wilmott R, Bush A, Deterding R, Ratjen F, editors. Kendig's disorders of the respiratory tract in children. Philadelphia: Elsevier; 2018. p. 769\u2013776.e2."},{"key":"1903_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/1756-0500-7-583","volume":"7","author":"S Martins Rda","year":"2014","unstructured":"Martins Rda S, Fonseca AC, Acosta FE, Folescu TW, Higa LY, Sad IR, Chaves CR, Cabello PH, Cabello GM. Severe phenotype in an apparent homozygosity caused by a large deletion in the CFTR gene: a case report. BMC Res Notes. 2014;7:583.","journal-title":"BMC Res Notes"},{"key":"1903_CR24","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/ijerph15092020","volume":"15","author":"A Zolin","year":"2018","unstructured":"Zolin A, Bossi A, Cirilli N, Kashirskaya N, Padoan R. Cystic fibrosis mortality in childhood. Data from European Cystic Fibrosis Society patient registry. Int J Environ Res Public Health. 2018;15:2020.","journal-title":"Int J Environ Res Public Health"},{"key":"1903_CR25","unstructured":"The Clinical and Functional Translation of CFTR (CFTR2) database. http:\/\/cftr2.org. Accessed 15 July 2019."},{"key":"1903_CR26","unstructured":"The Genome Aggregation Database (gnomAD) database. https:\/\/gnomad.broadinstitute.org\/. Accessed 15 July 2019."},{"key":"1903_CR27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s11033-018-4361-y","volume":"45","author":"LR Mota","year":"2018","unstructured":"Mota LR, de Melo Filho VM, de Castro LL, Garcia DF, Terse-Ramos R, Toralles MBP, de Lima RLLF, Souza EL. Description of rare mutations and a novel variant in Brazilian patients with cystic fibrosis: a case series from a referral center in the Bahia state. Mol Biol Rep. 2018;45:2045\u201351.","journal-title":"Mol Biol Rep"},{"key":"1903_CR28","unstructured":"The PubMed database. http:\/\/www.ncbi.nlm.nih.gov\/clinvar. Accessed 15 July 2019."},{"key":"1903_CR29","doi-asserted-by":"crossref","unstructured":"Glavac D, Ravnik-Glavac M, Dean M. Identification of a rare cystic fibrosis mutation (S4X) in a Slovenian population. Hum Mol Genet. 1993;2:315\u20136.","DOI":"10.1093\/hmg\/2.3.315"},{"key":"1903_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s004390050505","volume":"100","author":"M Desgeorges","year":"1997","unstructured":"Desgeorges M, M\u00e9garban\u00e9 A, Guittard C, Carles S, Loiselet J, Demaille J, Claustres M. Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities. Hum Genet. 1997;100:279\u201383.","journal-title":"Hum Genet"},{"key":"1903_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF00201673","volume":"93","author":"M Chill\u00f3n","year":"1994","unstructured":"Chill\u00f3n M, Casals T, Gim\u00e9nez J, Ramos MD, Palacio A, Morral N, Estivill X, Nunes V. Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes. Hum Genet. 1994;93:447\u201351.","journal-title":"Hum Genet"},{"key":"1903_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133890","volume":"10","author":"I Siryani","year":"2015","unstructured":"Siryani I, Jama M, Rumman N, Marzouqa H, Kannan M, Lyon E, Hindiyeh M. Distribution of cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a cohort of patients residing in Palestine. PLoS One. 2015;10:e0133890.","journal-title":"PLoS One"},{"key":"1903_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0873-2159(15)30514-6","volume":"11","author":"M Guardiano","year":"2005","unstructured":"Guardiano M, Vaz LG. Cystic fibrosis \u2013 clinical features of a sample of Portuguese patients. Rev Port Pneumol. 2005;11:381\u2013406.","journal-title":"Rev Port Pneumol"},{"key":"1903_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/01.gim.0000237793.19868.97","volume":"8","author":"A Kammesheidt","year":"2006","unstructured":"Kammesheidt A, Kharrazi M, Graham S, Young S, Pearl M, Dunlop C, Keiles S. Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens--implications for newborn screening. Genet Med. 2006;8:557\u201362.","journal-title":"Genet Med"},{"key":"1903_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/jpc.13096","volume":"52","author":"CY Ooi","year":"2016","unstructured":"Ooi CY, Jeyaruban C, Lau J, Katz T, Matson A, Bell SC, Adams SE, Krishnan U. High ambient temperature and risk of intestinal obstruction in cystic fibrosis. J Paediatr Child Health. 2016;52:430\u20135.","journal-title":"J Paediatr Child Health"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1903-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:13:50Z","timestamp":1609546430000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1903-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1903-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present investigation follows the international ethical guidelines and was approved by the board of the Hospital do Divino Espirito Santo de Ponta Delgada (HDES) after a favorable report by the Health Ethics Committee (Ref. HDES\/CES\/2016\/382). A written informed consent was obtained from all patients if adults (\u226518\u2009years old), or their parents or legally authorized representatives (<\u200918\u2009years old).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}